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King SJ, Bunz M, Chappell A, Scharl M, Docherty M, Jung B,
Lytle C, McCole DF. AMPK mediates inhibition of electrolyte
transport and NKCC1 activity by reactive oxygen species. Am J
Physiol Gastrointest Liver Physiol 317: G171–G181, 2019. First
published May 9, 2019; doi:10.1152/ajpgi.00317.2018.—Reactive
oxygen species such as H2O2 are believed to play a prominent role in
the injury and loss of transport function that affect the intestinal
epithelium in inflammatory conditions such as inflammatory bowel
diseases. Defects in intestinal epithelial ion transport regulation con-
tribute to dysbiosis and inflammatory phenotypes. We previously
showed that H2O2 inhibits Ca2!-dependent Cl" secretion across
intestinal epithelial cells (IECs) via a phosphatidylinositol 3-kinase
(PI3K)- and extracellular signal-regulated kinase (ERK)-dependent
mechanism that occurs, at least in part, through inhibition of the
basolateral Na!-K!-2Cl" cotransporter NKCC1. NKCC1 governs
Cl" entry into crypt IECs and thus plays a critical role in maintaining
the driving force for Cl" secretion. Electrolyte transport consumes
large amounts of cellular energy, and direct pharmacological activa-
tion of the cellular energy sensor AMP-activated protein kinase
(AMPK) has been shown to inhibit a number of ion transport proteins.
Here, we show that H2O2 activates AMPK in human IEC lines and ex
vivo human colon. Moreover, we demonstrate that the inhibitory
effect of H2O2 on Ca2!-dependent Cl" secretion and NKCC1 activity
is AMPK-dependent. This inhibitory effect is associated with a
physical interaction between AMPK and NKCC1, as well as increased
phosphorylation (Thr212,217) of NKCC1, without causing NKCC1
internalization. These data identify a key role for AMPK-NKCC1
interaction as a point of convergence for suppression of colonic
epithelial ion transport by inflammatory reactive oxygen species.
NEW & NOTEWORTHY H2O2 inhibition of intestinal epithelial
Ca2!-dependent Cl" secretion involves recruitment of AMP-acti-
vated protein kinase (AMPK) downstream of ERK and phosphatidyl-
inositol 3-kinase signaling pathways, physical interaction of AMPK
with the Na!-K!-2Cl" cotransporter NKCC1, and AMPK-dependent
suppression of NKCC1-mediated electrolyte influx without causing
NKCC1 internalization. It is intriguing that, in human intestinal
epithelial cell lines and human colon, H2O2 activation of AMPK
increased phosphorylation of NKCC1 residues required for promot-
ing, not inhibiting, NKCC1 activity. These data identify an elevated
complexity of AMPK regulation of NKCC1 in the setting of an
inflammatory stimulus.
carbachol; chloride; epithelial; HT-29; hydrogen peroxide; T84
INTRODUCTION
The overproduction of reactive oxygen species (ROS) dur-
ing active episodes of Crohn’s disease and ulcerative colitis is
thought to play an important role in the pathophysiology of
inflammatory bowel disease (IBD) (6, 51). A number of studies
have shown that chronically inflamed colonic tissue is subject
to significant oxidative stress due, in part, to decreased expres-
sion of endogenous antioxidants (12, 27, 33, 41). Therapeutic
approaches using broad-spectrum antioxidants, such as vitamin
E, or immunomodulatory agents that show antioxidant activity,
such as 5-aminosalicylic acid, have proven effective to differ-
ing degrees in treating IBD and reducing markers of oxidative
stress (52). In addition, antioxidants have proven effective in
delaying the onset of, and enhancing recovery from, colitis
including a protective effect against the onset of diarrhea in
mouse models (11, 37, 50).
H2O2 is among the most important ROS believed to have a
role in IBD, as it is a relatively stable and cell-permeable
precursor of numerous more-toxic oxygen radicals such as the
hydroxyl radical (38, 51, 69). Furthermore, the large influx of
activated phagocytes in ulcerative colitis may secrete millimo-
lar concentrations of H2O2 in close proximity to colonocytes
(64). Although pathophysiological concentrations of H2O2 can
cause damage, both direct and indirect, to cultured epithelial
cells and cells isolated from IBD patients via generation of
more ROS, H2O2 is also capable of more subtle influences on
cell function. H2O2 has emerged as an important cell-signaling
molecule involved in mediating responses to epidermal growth
factor and other growth factors (51), as well as participating in
MAPK and NF-#B signaling networks (20, 70). H2O2 has also
been shown to exert discreet, and often opposing, effects on ion
transport functions in intestinal tissue and colonic epithelial
cell lines. High concentrations (i.e., 5.5 mmol/l) of H2O2 have
been shown to induce a small increase in short-circuit current
(Isc), accounted for by Cl" secretion, across T84 colonic
epithelial cells (48). Other studies have shown that lower
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concentrations (500 $M) of H2O2 inhibit cAMP-dependent
Cl" secretion through specific effects on transport proteins
involved in Cl" transport, without evidence of toxic or injuri-
ous effects on cell monolayers (20, 67). The overall effect of
H2O2 on Cl" secretion appears to be one of suppression based
on studies of colonic epithelial cell lines and isolated mouse
colonic mucosa, consistent with the reduced ion-transporting
capability of intestinal tissues in the setting of inflammation (9,
35, 58). Indeed, we previously demonstrated that in vivo
administration of the H2O2-degrading antioxidant catalase to
mice alleviated ion transport dysfunction in dextran sulfate
sodium-induced colitis and that this effect was associated with
reduced H2O2 levels in the colonic mucosa (3).
In the intestinal tract, Ca2!-dependent Cl" secretion is
triggered by neuronal reflexes responding to changes in lumi-
nal composition, contact between luminal contents and the
epithelium, and physical distension (13). Cl" secretion serves
useful “housekeeping” functions, such as hydration of the
mucosal surface, dispersal of mucus and antimicrobial peptides
from the crypt, and flushing of noxious substances and patho-
genic bacteria. Thus, crypt fluid secretion is an important
component of intestinal homeostasis and protection of the host
epithelial barrier (47). Indeed, compromised secretory function
likely contributes to a decrease in the overall effectiveness of
the barrier, facilitating bacterial colonization of the intestinal
crypt and subsequent excessive inflammatory responses that
are a feature of diseases such as IBD. This hypothesis was
supported by studies demonstrating that CFTR-knockout mice
exhibit inflammation similar to that observed in IBD patients,
as well as pronounced changes in richness and diversity of the
intestinal microbiome (43, 49).
We previously demonstrated that H2O2 pretreatment is also
capable of inhibiting Ca2!-dependent Cl" secretion across
colonic epithelial cells via Ca2!-dependent activation of
MAPKs, phosphatidylinositol 3-kinase (PI3K), and functional
inhibition of the Na!-K!-2Cl" cotransporter NKCC1 (9).
NKCC1 is located on the basolateral membrane of colonic
epithelial cells at the crypt base and is the principal basolateral
uptake mechanism for secreted Cl" in crypt epithelium (2).
Therefore, inhibition of NKCC1 compromises the normal entry
of electrolytes into crypt epithelial cells and restricts secretory
capability (21). Decreased electrogenic secretory capacity is
associated with IBD and may be particularly relevant to loss of
crypt flushing and dispersal of antimicrobial peptides associ-
ated with inflammatory conditions (1, 4, 26, 34, 43, 65).
In our earlier work we established that the inhibitory effect
of H2O2 on Ca2!-dependent Cl" secretion across colonic
epithelial cells is mediated through activation of a number of
signaling kinases previously shown to negatively regulate
intestinal Cl" secretion (9, 36) and subsequent inhibition of
NKCC1 activity. However, the mechanism by which H2O2-
activated kinases inhibit NKCC1 and the signaling effector(s)
mediating this inhibition has not been identified. Therefore, in
the present study we set out to identify the mechanism by
which H2O2 inhibits NKCC1 by focusing on the cellular
energy sensor AMP-activated protein kinase (AMPK). AMPK
responds to metabolic stress, manifesting as depletion of ATP
levels and elevation of the AMP-to-ATP ratio (10, 31, 32) by
stimulating energy-producing pathways, such as glucose up-
take and glycolysis, while inhibiting energy-consuming pro-
cesses, such as protein and fatty acid synthesis (25, 28, 32). In
the intestinal epithelium, energy-consuming processes also
include electrolyte transport and maintenance of the epithelial
barrier. Indeed, previous studies have demonstrated that acti-
vation of AMPK suppresses intestinal ion transport and syn-
thesis of various proteins (28, 53). In the Cl"-secreting epithe-
lial cells within the colonic crypt, AMPK has been shown to
physically interact with and inhibit the CFTR Cl" channel
(67). In absorptive intestinal cells, AMPK can promote re-
moval of the epithelial Na! channel from the apical membrane
via increased activity of the ubiquitin ligase enzyme Nedd4-2
(5, 29, 30, 68). These effects would reduce the overall
ion-transporting capability of the intestinal epithelium, as
demonstrated in colonic tissues from the IL-10"/" mouse
model of colitis (67) and intestinal tissues from IBD patients
(26, 54, 57).
Therefore, the goal of this study was to determine whether
AMPK mediates H2O2-induced alterations in intestinal epithe-
lial Ca2!-dependent Cl" secretion and NKCC1 function. We
found that AMPK is activated by H2O2 in human colon and
intestinal epithelial cell (IEC) lines. H2O2 activation of AMPK
leads to physical interaction of AMPK with NKCC1 and
suppression of NKCC1 activity, and inhibition of AMPK
partially protects NKCC1 from inhibition by H2O2. Our data
indicate a novel role for the cellular energy sensor AMPK in
the regulation of a critical epithelial transport protein in a cell
model of inflammation. These findings may have implications
for suppression of ion transport function in the setting of
inflammatory conditions such as IBD.
MATERIALS AND METHODS
Materials. Carbachol (CCh), compound C (CC), and metformin
hydrochloride were obtained from Sigma (St. Louis, MO); wortman-
nin, LY294002, PD98059, 5-aminoimidazole-4-carboxamide-1-%-D-
ribofuranoside (AICAR), and H2O2 from Calbiochem (San Diego,
CA); mouse anti-phosphotyrosine antibodies from Upstate Biotech-
nology (Lake Placid, NY); anti-phosphorylated ERK antibodies from
New England Biolabs (Ipswich, MA); goat polyclonal anti-total
NKCC1 (N-16) and mouse monoclonal anti-total human NKCC1 (T4)
antibodies from Dr. C. Lytle (46); rabbit anti-lamin A/C antibody
from Santa Cruz Biotechnology (Santa Cruz, CA); rabbit anti-phos-
phorylated (Thr172) AMPK& antibody, rabbit anti-AMPK& antibody,
rabbit anti-phosphorylated (Ser473) Akt antibody, and rabbit anti-Akt
antibody from Cell Signaling Technology (Danvers, MA); and Tris-
glycine electrophoresis gels from Bio-Rad. Rabbit polyclonal anti-
human ERK1 (K-23; Santa Cruz Biotechnology) was used to measure
total ERK. The R5 anti-phosphorylated (Thr212,217) NKCC1 antibody
was a kind gift from Dr. Biff Forbush (22). All other reagents were of
analytical grade and obtained commercially.
Cell culture. Methods for maintenance of T84 cells (obtained from
primary stocks of Dr. Kim Barrett, University of California, San
Diego) in culture were described previously (9). Briefly, T84 cells
were grown in DMEM/F-12 medium (Mediatech, Herndon, VA)
supplemented with 5% newborn calf serum. For Ussing chamber/
voltage-clamp experiments, 5 ' 105 cells were seeded onto 12-mm
Millicell polycarbonate filters. For Western blot experiments, 106
cells were seeded onto 30-mm filters. Cells were cultured for 10–15
days before use. When grown on polycarbonate filters, T84 cells are
known to acquire the polarized phenotype of native colonic epithelia.
In accordance with muscarinic M3 receptor distribution on intestinal
epithelia, CCh was added basolaterally in all experiments. HT-
29.cl19A cells (from Dr. Kim Barrett) were grown to confluence (( 5
days) in DMEM supplemented with 10% FBS, 1% L-glutamine, and
streptomycin (100 $g/ml) in 75-cm2 flasks. Thereafter, the cells were
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seeded onto 12-mm Millicell polycarbonate filters for Ussing chamber
experiments or onto 30-mm filters for Western blotting, as described
above for T84 cells.
Physiological solutions. Composition of the Ringer solution used
for Ussing chamber, Western blot, and 86Rb! uptake studies was as
follows (in mM): 140 Na!, 120 Cl", 5.2 K!, 25 HCO3!, 0.4 H2PO4!,
2.4 HPO4
2!
, 1.2 Ca2!, 1.2 Mg2!, and 10 D-glucose.
Electrophysiological studies. T84 cells grown to confluence on
permeable 12-mm filters were mounted in Ussing chambers (0.6 cm2
window area) and bathed in oxygenated (95% O2-5% CO2) Ringer
solution at 37°C. Monolayers were voltage-clamped to zero potential
difference by application of Isc. Under these conditions, changes in Isc
in response to agonists are wholly reflective of electrogenic Cl"
secretion (8). Transepithelial resistance (TER) was measured using a
“chopstick” voltohmmeter (World Precision Instruments, Sarasota,
FL) (55, 56). The MEK inhibitor PD98059 was solubilized in DMSO.
In control studies, the final concentration of DMSO (0.1%) had no
effect on Isc responses to CCh in the presence or absence of H2O2
(data not shown). This finding is consistent with our previous unpub-
lished findings and with studies by other groups on MAPK phosphor-
ylation using IEC lines (39).
Human subjects. Control patients [n ) 3 (2 female and 1 male),
61 * 5 (range 52–71) yr old] presenting for colon cancer screening
were asymptomatic and showed no clinical or macroscopic signs of
acute or chronic inflammation. Individuals with a history of IBD or
intestinal inflammation at the time of the study were excluded. After
informed consent was obtained from the patients, a reusable round-
cup jumbo biopsy forceps (model no. FB-25 K-1, Olympus) was used
to obtain mucosal punch biopsies (~2 mm2 surface area) from mac-
roscopically normal-appearing regions of the sigmoid colon. Tissue
biopsies were placed in cold, oxygenated Ringer solution for transport
from the endoscopy suite to the laboratory. Tissues were allowed to
equilibrate at 37°C in Ringer solution for 20 min before incubation in
test solutions. Biopsies were then washed three times in ice-cold
Ringer solution before tissue homogenization in lysis buffer for
Western blot analysis (see below). The protocol was evaluated and
approved by the University of California, San Diego, Institutional
Review Board.
Immunoprecipitation and Western blotting. T84 cell monolayers
and tissue biopsies were washed three times with Ringer solution,
allowed to equilibrate for 30 min at 37°C, and then stimulated with
agonists (in the presence or absence of antagonists) as appropriate.
Fig. 1. H2O2 increases AMP-activated protein kinase (AMPK) phosphorylation in intestinal epithelial cells. T84 and HT-29.cl19a cells grown as monolayers on
semipermeable supports were treated bilaterally with H2O2 (500 $M) for 2–30 min or the AMPK activator 5-aminoimidazole-4-carboxamide-1-%-D-
ribofuranoside (AICAR, 2.5 mM) for 30 min. A: Western blot analysis of phosphorylation of the activating Thr172 residue on the catalytic &-subunit of AMPK.
Molecular mass (kDa) of each protein is shown at right. B: densitometric quantitation of Western blot results in A and normalization to total AMPK& levels.
C: CCh-induced change in ion transport reported as change in short-circuit current (+Isc). T84 monolayers mounted in Ussing chambers were not treated (control)
or preincubated with compound C (1–100 $M, bilaterally) for 30 min before administration of H2O2 (500 $M) for 30 min followed by stimulation of electrogenic
Cl" secretion with carbachol (CCh, 100 $M, basolaterally, n ) 4). D: change in ion transport reported as change in short-circuit current (+Isc). HT-29.cl19a
monolayers mounted in Ussing chambers were untreated (control) or pretreated with compound C (50 $M, bilaterally) for 30 min before administration of H2O2
(500 $M, bilaterally) for 30 min and subsequent CCh stimulation of ion transport (n ) 3). Values are means * SE. *P , 0.05, **P , 0.01 vs. control (B) and
vs. H2O2 ! CCh (C and D); #P , 0.05 vs. compound C (1 $M).
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The reaction was stopped by washing in ice-cold PBS, and the cells
were lysed in ice-cold lysis buffer (1% Triton X-100, 1 $g/ml
leupeptin, 1 $g/ml pepstatin, 1 $g/ml antipain, 100 $g/ml phenyl-
methylsulfonyl fluoride, 1 mM sodium vanadate, 1 mM sodium
fluoride, and 1 mM EDTA in PBS) for 45 min. Cell lysate superna-
tants were assayed for protein content (Bio-Rad protein assay kit) and
adjusted so that each sample contained an equal amount of protein.
For immunoprecipitation studies, lysates were incubated with immu-
noprecipitating antibody according to the manufacturer’s instructions
for 1 h at 4°C and then with protein A-Sepharose for 1 h at 4°C. For
NKCC1 immunoprecipitation, the goat polyclonal anti-total NKCC1
antibody (N-16) was used. Lysates were centrifuged for 3 min at
21,000 g, and the supernatant was discarded. The pellets were washed
three times in ice-cold PBS and resuspended in 2' gel loading buffer
[50 mM Tris (pH 6.8), 2% SDS, 200 mM dithiothreitol, 40% glycerol,
and 0.2% bromophenol blue] and boiled before separation by SDS-
polyacrylamide gel electrophoresis. Biopsy lysates were passed
through a needle, and insoluble material was removed by centrifuga-
tion at 350 g for 5 min at 4°C. The supernatant was centrifuged at
43,000 g for 30 min at 4°C, and pellets were resuspended in lysate
buffer. Lysate supernatants were assayed for protein content (Bio-Rad
protein assay kit) and adjusted so that each sample contained an equal
amount of protein. Aliquots of 20 $g of protein were separated by
polyacrylamide gel electrophoresis. Resolved proteins were trans-
ferred onto polyvinylidene difluoride membranes (NEN Life Science
Products, Boston, MA). Thereafter, the membrane was preblocked
with a 1% solution of blocking buffer (Upstate Biotechnology) for 30
min and then incubated for 1 h with the appropriate concentration of
primary antibody in 1% blocking buffer. After five 10-min washes in
Tris-buffered saline with 1% Tween, membranes were incubated for
30 min with a horseradish peroxidase-conjugated secondary antibody
(anti-mouse or anti-rabbit IgG; BD Biosciences, San Jose, CA) in 1%
blocking buffer. After five 10-min washes in Tris-buffered saline with
1% Tween, immunoreactive proteins were detected using an enhanced
chemiluminescence detection kit (Roche Molecular Biochemicals,
Indianapolis, IN) on film. National Institutes of Health Image software
was used for densitometric analysis of bands.
Basolateral 86 Rb! uptake studies. Basolateral K! uptake was
measured using 86Rb! as a tracer and an adaptation of a previously
described method (9). Confluent monolayers of T84 cells grown on
12-mm Transwell inserts were rinsed three times with warm Ringer
solution and incubated for 1 h at 37°C. After 1 h of preincubation,
cells were exposed bilaterally to H2O2 (500 $M) or vehicle control for
30 min on a warming plate at 37°C. Inserts were transferred to wells
containing Ringer solution with or without 100 $M CCh for 1 min
and then to wells containing Ringer solution with 1 $Ci/ml 86Rb! and
CCh and maintained at 37°C for 3 min. Inserts were immersed several
times in ice-cold 100 mM MgCl2 containing 10 mM Tris·HCl (pH
7.5) to terminate 86Rb! uptake. Filters were immediately excised
from the inserts and placed directly into 5 ml of scintillation fluid, and
86Rb! content was measured by standard scintillation methods. K!
influx ($mol K!·g protein"1·min"1) was calculated as (cpm·g
protein"1·min"1)/SA, where SA is the specific activity of the uptake
buffer (cpm/$mol K!).
siRNA transfection. T84 cells (2 ' 106) were seeded 3 days before
transfection and grown to 50–70% confluence in T75 flasks. Three
different annealed Silencer predesigned siRNA oligonucleotides tar-
geting AMPK&1 were obtained from Applied Biosystems (Foster
City, CA). For transfection reactions, 100 pmol of each of the three
gene-specific siRNA oligonucleotides were transfected into T84 cells
using the Nucleofector system (Amaxa, Gaithersburg, MD) according
to the manufacturer’s instructions. After transfection, T84 cells were
cultured on filter membranes for 48 h before further treatment. The
Fig. 2. H2O2 activation of AMP-activated protein kinase (AMPK) is down-
stream of ERK and phosphatidylinositol 3-kinase (PI3K) pathways. A: Western
blot analysis of AMPK, ERK, and Akt phosphorylation. T84 monolayers were
preincubated with the MEK inhibitor PD98059 (50 $M) or the PI3K inhibitor
wortmannin (50 nM) for 30 min before treatment with H2O2 (500 $M) for 5
min. Molecular mass (kDa) of each protein is shown at right. B: densitometric
quantitation of Western blot results in A and normalization to total AMPK&
levels (n ) 3). Values (arbitrary units) are means * SE. *P , 0.05 vs.
control/untreated; #P , 0.05 vs. H2O2 alone.
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Fig. 3. H2O2 inhibits basolateral K! influx and activity of the Na!-K!-
2Cl" cotransporter NKCC1. T84 monolayers were pretreated with the
AMP-activated protein kinase (AMPK) inhibitor compound C (50 $M) or
Ringer solution (control) and then incubated with vehicle control or H2O2
(500 $M) for 30 min. Cells were subsequently transferred to Ringer
solution or Ringer solution ! carbachol (CCh, 100 $M, basolaterally) for
1 min and then to a basolateral 86Rb!-containing buffer for 3 min (n ) 4).
Values are means * SE. **P , 0.01 vs. control/untreated cells; #P , 0.05
vs. CCh alone.
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nonspecific control siRNA SMARTpool (100 pmol; Upstate Biotech-
nology/Dharmacon, Chicago, IL) was used as a negative control.
NKCC1 biotinylation assay. NKCC1 surface expression was deter-
mined as previously described (7). Briefly, T84 monolayers were
treated with 500 $M H2O2 with or without 30 min of pretreatment
with compound C (50 $M), metformin (5 mM) alone, or capsaicin (20
$M) alone. After treatment, monolayers were washed twice with
ice-cold 1' PBS (pH 8.0). EZ-Link Sulfo-NHS-SS-biotin (10 $M;
Thermo Fisher Scientific) was added basolaterally, and monolayers
were incubated for 30 min at 4°C. Fresh biotin was added, and
monolayers were incubated for an additional 30 min. Monolayers
were washed twice with ice-cold 1' PBS (pH 8.0), incubated in
quenching buffer [100 mM glycine in 1' PBS (pH 8.0)] for 15 min,
and then aspirated. Radioimmunoprecipitation lysis buffer (500 $l)
was added, and monolayers were incubated for 30 min at 4°C with
gentle agitation. Cells were scraped and collected into 1.7-ml tubes
and then subjected to sonication (QSonica) for 30 s (10 s on/off) at
30% amplitude. Lysates were centrifuged at 4°C for 10 min at 16,200
g, and the supernatant was aspirated into new tubes. Protein was
quantified using a bicinchoninic acid assay (Pierce). Pierce streptavi-
din-agarose resin (50 $l; Thermo Fisher Scientific) was placed in
1.7-ml tubes and washed according to the manufacturer’s instructions.
Equal concentrations of protein (~1 mg/ml) were added to respective
streptavidin-bead aliquots, which were then incubated overnight at
4°C with rotation. On the following day, samples were centrifuged
according to instructions of the manufacturer of the streptavidin-
agarose beads. Supernatants were aspirated into new tubes for total
NKCC1 samples. Beads were washed twice with a high-salt buffer
[0.1% Triton X-100, 500 mM NaCl, 50 mM Tris, and 5 mM EDTA
(pH 7.5)] for 10 min and once with a low-salt buffer [0.1% Triton
X-100, 100 mM NaCl, 50 mM Tris, and 5 mM EDTA (pH 7.5)] for
10 min. Biotinylated proteins were eluted from streptavidin beads
using 50 $l of Laemmli sample buffer (Bio-Rad). Samples were run
on 8% SDS-PAGE and transferred to polyvinylidene difluoride mem-
branes.
Statistical analysis. All data are expressed as means * SE for a
series of n experiments. Student’s t-test or ANOVA with the Student-
Newman-Keuls post test was used to compare mean values as appro-
priate. P , 0.05 was considered to represent significant difference.
RESULTS
H2 O2 inhibits CCh-stimulated Cl" secretion through acti-
vation of AMPK. The metabolic-sensing serine-threonine ki-
nase AMPK has been shown to play an important role in
restoration of cellular energy levels under conditions of meta-
bolic stress, including after exposure to oxidants such as H2O2
(10, 31, 32). AMPK activation occurs in response to AMP
binding or via activation by upstream kinases (14). Moreover,
binding of AMP to AMPK makes AMPK a better substrate for
kinase activation, resulting in phosphorylation of its catalytic
&-subunit on the Thr172 residue, with a 50- to 100-fold increase
in enzyme activity (14). Therefore, we measured phosphory-
lation (Thr172) of AMPK& to investigate whether H2O2 in-
creases activation of AMPK. H2O2 increased phosphorylation
transiently, with a maximal effect between 5 and 15 min (P ,
0.05–0.01, n ) 7; Fig. 1, A and B). The AMPK activator
AICAR, administered for 30 min, also significantly increased
AMPK& phosphorylation (P , 0.05, n ) 4; Fig. 1, A and B).
While AMPK has been shown to inhibit cAMP-dependent Cl"
secretion through effects on CFTR, its effects on Ca2!-depen-
dent epithelial Cl" secretion have not been determined (29,
67). Consequently, we investigated whether AMPK activation
was involved in the inhibitory effect of H2O2 on Ca2!-depen-
dent Cl" secretion stimulated by the acetylcholine analog CCh.
Pretreatment of T84 monolayers with the specific AMPK
inhibitor compound C (1–100 $M) blocked H2O2-mediated
inhibition of CCh-stimulated Cl" secretion, indicating that
AMPK is involved in H2O2 inhibition of Ca2!-dependent Cl"
secretion (50 $M compound C, P , 0.05, n ) 4; Fig. 1C). This
finding was also observed in HT-29.cl19a monolayers, where
the inhibitory effect of H2O2 was significantly blocked by
pretreatment with compound C (P , 0.05; Fig. 1D).
Fig. 4. H2O2 induces AMP-activated protein kinase (AMPK)-Na!-K!-2Cl"
cotransporter type 1 (NKCC1) association. T84 monolayers were treated
with H2O2 (500 $M) for 2–30 min or the AMPK activator 5-aminoimida-
zole-4-carboxamide-1-%-D-ribofuranoside (AICAR, 2.5 mM) for 30 min.
Cell lysates were immunoprecipitated with anti-AMPK& (A) or anti-
NKCC1 (N-16) antibody (B) and subsequently probed for NKCC1 and/or
AMPK& binding by Western blotting. The catalytic &-subunit of AMPK
was immunoprecipitated (IP) and immunoblotted (Blot) for NKCC1 (T4
antibody). Results from blots were quantified by densitometric analysis
(n ) 4). Molecular mass of each protein (kDa) is shown at right. Values
(arbitrary units) are means * SE and were normalized to total levels of the
primary immunoprecipitate (AMPK& or NKCC1). *P , 0.05, **P , 0.01,
***P , 0.001 vs. control/untreated cells.
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H2 O2 -induced AMPK phosphorylation occurs downstream
of PI3K and ERK activation. We previously demonstrated that
the inhibitory effect of H2O2 on CCh-stimulated Isc involves
activation of two separate, but Ca2!-dependent, signaling path-
ways. One pathway involves activation of Src, Pyk-2, and
ERK/p38 MAPK while the other involves p38-dependent ac-
tivation of PI3K (9). We therefore investigated whether these
signaling pathways are also involved in activation of AMPK by
H2O2. Preincubation of T84 monolayers with the MEK1 in-
hibitor PD98059 or the PI3K inhibitor wortmannin reduced
phosphorylation of AMPK& in response to H2O2 (P , 0.05–
0.001, n ) 3; Fig. 2). AMPK phosphorylation levels in mono-
layers treated with PD98059 or wortmannin alone were not
statistically different from those in monolayers treated with
either agent in the presence of H2O2. Consistent with our
previous findings, MEK1 inhibition had no effect on H2O2-
stimulated PI3K signaling measured by Akt phosphorylation;
similarly, PI3K inhibition by wortmannin had no effect on
ERK phosphorylation, whereas it successfully reduced Akt
phosphorylation (Fig. 2A). These data indicate that the ERK
and PI3K signaling pathways activated by H2O2 converge at
the level of AMPK.
AMPK activity mediates H2 O2 inhibition of NKCC1. Our
prior work indicated that H2O2 pretreatment inhibits CCh-
stimulated NKCC1 activity, as measured by bumetanide-sen-
sitive 86Rb! influx, and that the inhibitory effect of H2O2 does
not involve changes in intracellular Cl" (a major regulator of
NKCC1 activity) (9). Further experiments explored whether
H2O2 inhibition of CCh-stimulated K! influx also involves
AMPK activation. Preincubation of T84 monolayers with the
AMPK inhibitor compound C (50 $M) for 30 min reversed the
inhibitory effect of H2O2 on CCh-stimulated 86Rb! influx
(P , 0.01 vs. Ringer solution, n ) 4; Fig. 3), while there was
no significant difference in 86Rb! influx between CCh alone
and CCh in the presence of compound C. These data indicate
that H2O2 inhibition of Ca2!-dependent K! uptake, likely via
NKCC1 based on our prior studies, is mediated, at least in part,
through AMPK activation.
AMPK physically associates with NKCC1 in IECs. AMPK
activators such as AICAR and A-769662 have been shown to
have no effect or to inhibit NKCC1 activity, with the latter
effect due, in part, to phosphorylation at the NH2 terminus (23,
60). To determine whether AMPK inhibits NKCC1 through a
physical association, we used lysates from T84 cells treated
with H2O2 to carry out coimmunoprecipitation experiments
(Fig. 4). We observed a significant level of coimmunoprecipi-
tation of AMPK and NKCC1 (detected with anti-NKCC1 T4
antibody), regardless of whether AMPK or NKCC1 was ini-
tially immunoprecipitated [P , 0.01, n ) 3 (Fig. 4A); P ,
0.05, n ) 3 (Fig. 4B)]. Thus, inhibition of NKCC1 by AMPK
could involve a direct association between the two proteins.
Fig. 5. H2O2 increases Na!-K!-2Cl" cotransporter type 1 (NKCC1) phos-
phorylation in human colon and in cell lines in an AMP-activated protein
kinase (AMPK)-dependent manner. A: H2O2 treatment of T84 monolayers
significantly increased phosphorylation (Thr212,217) of NKCC1 (500 $M, P ,
0.05, n ) 4). Treatment with 5-aminoimidazole-4-carboxamide-1-%-D-ribo-
furanoside (AICAR, 2.5 mM) for 30 min also increased NKCC1 (Thr212,217)
phosphorylation (P , 0.05, n ) 4). B: experiment described in A was repeated
in ex vivo human colonic biopsies from control subjects without active
inflammatory intestinal disease (n ) 3). H2O2 (1 mM) also increased AMPK&
(Thr172) phosphorylation in human colonic tissue. C: preincubation of T84
monolayers with compound C (50 $M, bilaterally) for 30 min significantly
reduced H2O2 induction of NKCC1 phosphorylation (P , 0.01, n ) 4).
Densitometric data (arbitrary units) are presented as means * SE for levels of
phosphorylation and normalized to total NKCC1 levels. *P , 0.05, **P ,
0.01, ***P , 0.001 vs. vehicle control; &P , 0.05 vs. compound C control;
##P , 0.01 vs. vehicle H2O2.
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H2 O2 modifies the phosphorylation status of NKCC1
through AMPK. Full activity of human NKCC1 requires phos-
phorylation of Thr residues at positions 212 and 217 (16). We
therefore explored whether H2O2 affects NKCC1 phosphory-
lation and whether this involves AMPK activation. We were
surprised to find that treatment of T84 monolayers with H2O2
(500 $M) induced a rapid increase in phosphorylation
(Thr212,217) of NKCC1 that peaked at 15 min (P , 0.05, n )
4; Fig. 5A). The AMPK activator AICAR also significantly
increased NKCC1 phosphorylation (P , 0.05, n ) 4; Fig. 5A).
These findings were reproduced using human colonic mucosal
biopsies isolated from subjects who were undergoing routine
colorectal cancer screening but showed no evidence of intes-
tinal inflammation. Ex vivo treatment with H2O2 (1 mM) and
subsequent Western blotting for phosphorylated and total
forms of NKCC1 and AMPK showed that H2O2 increased
NKCC1 (Thr212,217), as well as AMPK (Thr172), phosphoryla-
tion (n ) 3; Fig. 5B). Follow-up studies in T84 cells showed
that H2O2-stimulated phosphorylation of NKCC1 was signifi-
cantly reduced by preincubation with the AMPK inhibitor
compound C (P , 0.01, n ) 4; Fig. 5C). These data indicate
that H2O2 actually increases phosphorylation of NKCC1 resi-
dues required for NKCC1 activity.
H2 O2 -activated AMPK does not promote internalization of
membrane-bound NKCC1. NKCC1 has also been shown to be
regulated via internalization of membrane-bound NKCC1 in
colonic epithelial cells (7). Therefore, we employed a surface
biotinylation assay to determine if surface expression of
NKCC1 is altered and if NKCC1 internalization is AMPK-
dependent. Monolayers of T84 cells were treated with H2O2
with or without pretreatment with the AMPK inhibitor com-
pound C (50 $M), metformin (5 mM) alone as a positive
control for AMPK activation, or capsaicin (20 $M) alone as a
positive control for NKCC1 internalization (7, 67). After treat-
ment, proteins expressed in the basolateral membrane were
biotinylated and pulled down by immunoprecipitation with
streptavidin-coated agarose beads. We observed no significant
change in NKCC1 surface expression in response to H2O2
treatment, as well as no effect of compound C pretreatment,
although there appeared to be an increasing trend of NKCC1
surface expression with H2O2 treatment (Fig. 6). Furthermore,
AMPK activation by metformin (5 mM) did not alter NKCC1
internalization. Capsaicin (20 $M) also did not induce NKCC1
internalization, despite our use of a previously established
incubation time and concentration of capsaicin that were
shown to promote NKCC1 internalization in T84 cells (7). Our
data suggest that H2O2 inhibition of Cl" secretion is indepen-
dent of NKCC1 internalization and that AMPK does not
mediate distinct patterns of membrane turnover of NKCC1.
DISCUSSION
Regulation of epithelial transport is a complex and multi-
faceted physiological process that requires careful orchestra-
tion of acute vs. chronic and transient vs. sustained events. In
the acute regulation of electrolyte transport in response to
exposure by ROS, we investigated whether the cellular energy
sensor AMPK, itself capable of acute and/or sustained regula-
tion of many metabolic events, was involved in the H2O2
regulation of Ca2!-dependent ion transport. We previously
showed that H2O2 inhibits CCh-stimulated Cl" secretion (9).
CCh is a more stable analog of the neurotransmitter acetylcho-
line that plays a prominent role in the minute-to-minute regu-
lation of fluid secretion in intestinal crypts through activation
of Ca2!-dependent signals following binding to muscarinic
receptors on IECs (2). We further found that the inhibitory
Fig. 6. AMP-activated protein kinase (AMPK) inhibition of
the Na!-K!-2Cl" cotransporter NKCC1 is independent of
internalization. NKCC1 surface expression was detected
using a biotinylation assay, where biotinylation indicated
membrane insertion. H2O2 treatment of T84 monolayers
slightly, but not statistically significantly, increased surface
expression of NKCC1 (500 $M; n ) 3). Pretreatment with
the AMPK inhibitor compound C (CC, 50 $M, bilaterally)
for 30 min did not decrease NKCC1 internalization. Neither
metformin (Metf, 5 mM, bilaterally; n ) 3) nor capsaicin
(Cap, 20 $M, bilaterally, n ) 3) treatment significantly
altered surface expression of NKCC1. Densitometric data
(arbitrary units) are presented as means * SE for levels of
biotinylated NKCC1 and normalized to total NKCC1 lev-
els.
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effect of H2O2 occurred by virtue of its ability to reduce the
activity of the basolateral NKCC1, which is responsible for
basolateral Cl" entry into IECs and is critically involved in
overall epithelial homeostasis (9). This finding was supported
by in vivo studies showing that administration of the antioxi-
dant enzyme catalase, which degrades H2O2, restricted the
suppression of colonic ion transport responsiveness and re-
duced levels of colonic epithelial NKCC1 caused by dextran
sulfate sodium-induced colitis (3). In the present study we
showed that AMPK activity is a critical mediator of the
inhibitory effect of H2O2 on Cl" secretion and NKCC1 activ-
ity. H2O2 increased phosphorylation (Thr172) of AMPK& in
human colonic epithelial cell lines and in ex vivo human
colonic mucosal biopsies. While there was some variability
between human samples from different patients with respect to
the magnitude and kinetics of H2O2 induction of AMPK& and
NKCC1 phosphorylation, the overall effect of H2O2 as a
stimulus of phosphorylation of these proteins was consistent
and, thus, broadly aligned with our cell line data. The AMPK
inhibitor compound C dramatically reduced the inhibitory
effect of H2O2 on overall ion transport and CCh-stimulated
NKCC1 activity. The inhibitory effect of H2O2 on NKCC1
activity was associated with an increased physical association
between AMPK and NKCC1 based on reciprocal coimmuno-
precipitation studies. Since NKCC1 activity is dependent on
phosphorylation of regulatory Thr212 and Thr217 residues (16,
22, 44, 45), we investigated if H2O2 had an effect on NKCC1
phosphorylation. Using the R5 antibody, which recognizes
phosphorylation of these residues, we were surprised to find
that H2O2 actually increases NKCC1 phosphorylation in both
IEC lines and human colonic biopsies, even while H2O2
exerted an inhibitory effect on overall NKCC1 activity. Phos-
phorylation of NKCC1 at its regulatory Thr212 and Thr217
residues in response to H2O2 appears, ultimately, to require
AMPK activity, since both AICAR and H2O2 elicited NKCC1
phosphorylation in a manner antagonized by compound C.
AMPK activity has been linked to inhibition of renal-
specific NKCC2 and, recently, to NKCC1 activity in in vitro
model systems. This was shown to occur in response to
selective activators of AMPK, such as AICAR and A-769662,
and also in response to osmotic shrinkage (23, 24, 60). How-
ever, in these studies, AMPK phosphorylation of NKCC1 at
Ser38 and Ser214 (dogfish sequence), corresponding to Ser77
and Ser242 in human NKCC1, was, in fact, associated with
reduced NKCC1 activity. The consensus amino acid sequence
that is associated with AMPK binding and Ser/Thr phosphor-
ylation involves the following recognition motif: -(X%)XXS/
TXXX-, where - is a hydrophobic residue (M, V, L, I, or F),
% is a basic residue (R, K, or H), and the parentheses indicate
that the order of residues at the P-4 and P-3 positions is not
essential (15, 60). The sequence surrounding Ser242 of human
NKCC1 loosely fits the AMPK consensus recognition motif,
with an Arg residue at the P-2, rather than P-3, position (60).
Additional studies with cell-free assays showed increased
phosphorylation of Ser77 following AMPK activation by phen-
formin, while a NKCC1 construct with a point mutation at
Ser77 showed less phosphorylation and a 16% decrease in the
inhibitory effect of phenformin on NKCC1 transport of 86Rb!,
thus indicating a partial role for this residue in AMPK regula-
tion of NKCC1 (23). One caveat is that phenformin can exert
AMPK-independent signaling events (66).
Further studies indicate that AMPK can inhibit activity of
Ste-related proline-alanine-rich kinase (SPAK)/oxidative stress-
responsive kinase (OSR1), which phosphorylates and activates
NKCC1 in response to several stimuli (17, 60). However, there
does appear to be a context- and cell type-dependent pattern of
regulation of NKCC1 by AMPK that is not always consistent
with NKCC1 phosphorylation levels or kinetics. Indeed, this is
not an unusual feature of AMPK, as it has been shown to play
context-specific roles in tumorigenesis (42). Interestingly, the
cell type-specific effects of individual AMPK activators were
emphasized by the use of A-769662: Sid et al. observed that
A-769662, while increasing phosphorylation of Ser242, had no
effect on NKCC1 activity in erythrocytes (60), whereas Fraser
et al. observed inhibition of NKCC1 activity by A-769662 in
Madin-Darby canine kidney cells (23). There also appear to be
important differences between the effects of basal and stimu-
lated AMPK activity in the regulation of NKCC1: Davies et al.
observed that in erythrocytes the constitutive absence or sup-
pression of AMPK activity could regulate SPAK/OSR1
through mechanisms different from those invoked by acute
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Fig. 7. Signaling pathways activated by H2O2 to inhibit Na!-K!-2Cl" cotrans-
porter NKCC1 converge at AMP-activated protein kinase (AMPK). H2O2
stimulates an increase in cytosolic Ca2! concentration (1). Two separate
Ca2!-stimulated signaling pathways [Src-Pyk2-ERK and p38- phosphatidyl-
inositol 3-kinase (PI3K)] are activated (2 ). These pathways converge to
increase AMPK activation (3). H2O2 also inhibits basolateral Ca2!-responsive
K! influx mediated by NKCC1 in an AMPK-dependent manner, and H2O2
increases physical association of AMPK with NKCC1 and increases NKCC1
phosphorylation via AMPK activity (4 ). Suppression of NKCC1 activity likely
contributes to the overall inhibitory effect of H2O2 on Ca2!-dependent ion
transport in colonic epithelial cells (5 ).
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changes in AMPK activity (17). Furthermore, the nuanced
regulation of NKCC1 activity was also emphasized by findings
that the extent of NKCC1 phosphorylation did not directly
correlate with NKCC1 activation by hyperosmolarity in mouse
erythrocytes; thus, Sid et al. concluded that other factors are
likely involved (60).
Even though we observed an increase in H2O2-stimulated
phosphorylation of two key residues (Thr212 and Thr217) that
are required for increasing NKCC1 activity, increased AMPK
activity in Madin-Darby canine kidney cells treated with the
AMPK activator A-769662 correlated with reduced NKCC1
phosphorylation on Thr212 and Thr217 (23). Our studies indi-
cate a clear functional role for H2O2-activated AMPK in
inhibiting Ca2!-dependent electrolyte transport and NKCC1
activity (cf. Figs. 1A, 2, and 4A). We also observed a partial,
although not statistically significant, increase in NKCC1 phos-
phorylation in cells incubated with compound C alone (cf. Fig.
5), with no effect on NKCC1 activity (cf. Fig. 3), which is
consistent with the findings of Fraser et al. (23). Our results
suggest that AMPK may have a dual role with respect to
NKCC1 phosphorylation in unstimulated/resting conditions vs.
that in response to an inflammatory stimulus. Moreover, we
did not see an increase in 86Rb! flux in colonic epithelial
cells treated with compound C alone, which is also in
agreement with the findings of Fraser et al. (23). AMPK
activity is also stimulus-specific, as well-established activa-
tors such as AICAR and A-769662 act via different mech-
anisms. AICAR is phosphorylated by adenylate kinase to
generate the AMP analog ZMP, which directly binds to the
&-subunit of AMPK, while A-769662 allosterically activates
AMPK through binding to its regulatory %1-subunit (14, 59).
Indeed, coadministration of these agents has been shown to
have a synergistic effect with respect to AMPK activation in
mouse hepatocytes (19). Another important consideration of
select activators of AMPK is their potential for off-target
effects. AICAR and metformin have been shown to inhibit prolif-
eration by AMPK-independent mechanisms, while A-769662 can
effectively inhibit proteasomal activity, which is relevant to the
study of NKCC1 function, since NKCC1 can be regulated by
proteasomal degradation (18, 42).
With respect to the stimulus used to activate AMPK in these
studies, several groups have reported that oxidative stress can
activate AMPK in a cell type-specific manner independently of
alterations in the AMP-to-ATP ratio (reviewed in Refs. 40 and
61). We previously demonstrated that H2O2, at doses used in
the present study and in the same cell lines, did not cause
disruption of barrier function in T84 cells, thus indicating that
cell integrity is maintained (9). Our previous work demon-
strated that H2O2 caused a sustained increase in intracellular
Ca2! levels that triggered activation of two signaling path-
ways, leading to increased phosphorylation of MEK and Akt
downstream of PI3K. Our data suggest that these pathways
feed into AMPK phosphorylation, as phosphorylated AMPK
levels were reduced by ERK or PI3K inhibition (cf. Fig. 3).
Our biotinylation-based internalization assays did not detect a
clear effect of H2O2 on membrane localization of NKCC1,
although there was a counterintuitive trend toward increased
membrane localization. This pattern was also observed in
response to capsaicin treatment, which was included as a
positive control to promote internalization based on a previous
study (7). Given the lack of a significant effect of H2O2 on
membrane NKCC1 levels, we interpret our findings as indicat-
ing that H2O2-AMPK signaling primarily inhibits NKCC1 by
altering its activation status, rather than by causing a substan-
tial internalization of NKCC1 away from the basolateral mem-
brane.
In conclusion, we have demonstrated that pathophysiologi-
cally relevant concentrations of H2O2 can inhibit Ca2!-depen-
dent Cl" secretion by activating kinase-signaling pathways,
leading to activation of AMPK and inhibition of NKCC1
activity and, overall, ion transport responsiveness (Fig. 7). Our
findings emphasize the context-dependent nature of the rela-
tionship between AMPK and NKCC1 but are consistent with
an overall inhibitory effect of H2O2 and AMPK on the ion-
transporting capability of IECs that aligns with the loss of
transport capacity in intestinal inflammation (35). In agreement
with the findings of others, it appears that regulation of
NKCC1 activity is more complex than a linear and uniform
series of protein kinase signals and may involve multiple
protein kinase complexes acting in different cell types and
resulting in varied outcomes determined by specific stimuli
(62, 63). The findings in our study serve to further expand our
understanding of how AMPK may act to negatively regulate
energy-consuming cellular activities in epithelia in the setting
of inflammation.
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